SBI Securities’s AEON Biopharma AEON Stock Holding History

SBI Securities’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$99	Buy	329 +97	+42%	+$30	﹤0.01%	3582
2026 Q2	$167	Buy	232 +127	+121%	+$106	﹤0.01%	3374
2026 Q1	$103	Hold	105	–	–	﹤0.01%	3397
2025 Q4	$116	Sell	105 -1	-0.9%	-$1	﹤0.01%	3362
2025 Q3	$86	Hold	106	–	–	﹤0.01%	3558
2025 Q2	$81	Hold	106	–	–	﹤0.01%	3598
2025 Q1	$61	Buy	106 +105	+10,500%	+$748	﹤0.01%	3590
2024 Q4	$56	Buy	+1	New	+$58	﹤0.01%	3611

Other funds holding AEON

Beacon Wealthcare LLC Raleigh, North Carolina $315M AUM 8.23% 1-Year Est. Return

Wolff Wiese Magana Carslbad, California $218M AUM 37.48% 1-Year Est. Return

DCM

Dupont Capital Management Wilmington, Delaware $14.8M AUM 14.32% 1-Year Est. Return

GHP Investment Advisors Denver, Colorado $2.68B AUM 19.3% 1-Year Est. Return

SBI Securities's AEON Position: Q3 2026 in Review

SBI Securities increased its AEON Biopharma (AEON) stake by 42% in Q3 2026, buying an estimated $30 and bringing the position to 329 shares worth $99. The position accounts for ﹤0.01% of the portfolio, ranked #3582.

SBI Securities first reported a position in AEON in Q4 2024 and has held it in 8 quarters since. The position peaked at $167 in Q2 2026. 6 funds tracked by Wall St. Rank hold AEON as of Q3 2026.

SBI Securities held 329 shares of AEON Biopharma worth $99 as of Q3 2026.
SBI Securities bought 97 AEON Biopharma shares in Q3 2026, an estimated $30.
AEON Biopharma made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3582 holding.
SBI Securities first reported a position in AEON Biopharma in Q4 2024 and has held it in 8 quarters since.
SBI Securities's AEON Biopharma position peaked at $167 in Q2 2026.
6 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.